Related Experiment Video
Updated: Dec 29, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
The iron chelator Deferasirox causes severe mitochondrial swelling without depolarization due to a specific effect on
Esther M Gottwald1, Claus D Schuh1, Patrick Drücker2
1Institute of Anatomy, University of Zurich, Zurich, Switzerland.
Abstract:
The iron chelator Deferasirox (DFX) causes severe toxicity in patients for reasons that were previously unexplained. Here, using the kidney as a clinically relevant in vivo model for toxicity together with a broad range of experimental techniques, including live cell imaging and in vitro biophysical models, we show that DFX causes partial uncoupling and dramatic swelling of mitochondria, but without depolarization or opening of the mitochondrial permeability transition pore. This effect is explained by an increase in inner mitochondrial membrane (IMM) permeability to protons, but not small molecules. The movement of water into mitochondria is prevented by altering intracellular osmotic gradients. Other clinically used iron chelators do not produce mitochondrial swelling. Thus, DFX causes organ toxicity due to an off-target effect on the IMM, which has major adverse consequences for mitochondrial volume regulation.
Insights
The iron chelator Deferasirox (DFX) causes severe organ toxicity by inducing mitochondrial swelling. This occurs due to increased proton permeability of the inner mitochondrial membrane, an off-target effect not seen with other iron chelators.
Area of Science:
- Biochemistry
- Cell Biology
- Toxicology
Background:
- Deferasirox (DFX) is an iron chelator used clinically.
- DFX causes severe, unexplained toxicity in patients.
- Mitochondrial dysfunction is implicated in various toxicities.
Purpose of the Study:
- To elucidate the mechanism behind Deferasirox-induced toxicity.
- To investigate the effects of DFX on mitochondria in vivo and in vitro.
- To determine if DFX's effects are specific to its iron-chelating properties.
Main Methods:
- In vivo kidney toxicity model.
- Live cell imaging.
- In vitro biophysical models.
- Mitochondrial function assays.
Main Results:
- DFX causes partial mitochondrial uncoupling and dramatic swelling.
- Mitochondrial swelling occurs without depolarization or pore opening.
- DFX increases inner mitochondrial membrane proton permeability.
- Intracellular osmotic gradients prevent water movement into mitochondria.
- Other iron chelators do not induce mitochondrial swelling.
Conclusions:
- DFX causes organ toxicity via an off-target effect on the inner mitochondrial membrane.
- This off-target effect disrupts mitochondrial volume regulation.
- The mechanism of DFX toxicity is distinct from its iron-chelating activity.
More Related Videos
07:17Improving the Accuracy of Flow Cytometric Assessment of Mitochondrial Membrane Potential in Hematopoietic Stem and Progenitor Cells Through the Inhibition of Efflux Pumps
Published on: July 30, 2019
05:36Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
Published on: February 23, 2024
Related Concept Videos
The Inner Mitochondrial Membrane
Mitochondrial Membranes
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Protein Transport into the Inner Mitochondrial Membrane
Transport of mitochondrial precursors across the TIM23 channel is driven by...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Porin Insertion in the Outer Mitochondrial Membrane
Three models describe the assembly of porins by the SAM complex and their insertion into the outer membrane. Model 1 suggests that porins are assembled outside the SAM channel as the...